Highly efficient method of preparing human catalytic antibody light chains and their biological characteristics
Authors:
Open Access
- 28 December 2011
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 26 (4) , 1607-1615
Abstract
The ultimate goal of catalytic antibody research is to develop new patient therapies that use the advantages offered by human catalytic antibodies. The establishment of a high‐throughput method for obtaining valuable candidate catalytic antibodies must be accelerated to achieve this objective. In this study, based on our concept that we can find antibody light chains with a high probability of success if they include a serine protease‐like catalytic triad composed of Ser, His, and Asp on a variable region of the antibody structure, we amplified and cloned DNAs encoding human antibody light chains from germline genes of subgroup II by seminested PCR using two primer sets designed for this purpose. Seven DNA fragments encoding light chains in 17 clones were derived from germline gene A18b, 6 DNA fragments from A3/A19, 2 DNA fragments from A17, and a clone DNA fragment from A5 and O11/O1. All light chains expressed in Escherichia coli and highly purified under nondenaturing conditions exhibited amidolytic activity against synthetic peptides. Some of the light chains exhibited unique features that suppressed the infectious activity of the rabies virus. Furthermore, the survival rate of mice in which a lethal level of the rabies virus was coinoculated directly into the brain with light chain 18 was significantly improved. In the case of humans, these results demonstrate that high‐throughput selection of light chains possessing catalytic functions and specificity for a target molecule can be attained from a light‐chain DNA library amplified from germline genes belonging to subgroup II.—Hifumi, E., Honjo, E., Fujimoto, N., Arakawa, M., Nishizono, A., Uda, T. Highly efficient method of preparing human catalytic antibody light chains and their biological characteristics. FASEB J. 26, 1607–1615 (2012). www.fasebj.orgKeywords
Funding Information
- Japan Science and Technology Agency
- Core Research for Evolutional Science and Technology
This publication has 26 references indexed in Scilit:
- Isolation and characterization of novel human monoclonal antibodies possessing neutralizing ability against rabies virusMicrobiology and Immunology, 2010
- Immunological Origin and Functional Properties of Catalytic Autoantibodies to Amyloid β PeptideJournal of Clinical Immunology, 2010
- A Human Germ Line Antibody Light Chain with Hydrolytic Properties Associated with Multimerization StatusJournal of Biological Chemistry, 2009
- Catalytic antibodies to HIV: Physiological role and potential clinical utilityAutoimmunity Reviews, 2008
- Crystal structure of a glycosylated Fab from an IgM cryoglobulin with properties of a natural proteolytic antibodyBiochemical Journal, 2006
- Super catalytic antibody and antigenaseJournal of Bioscience and Bioengineering, 2004
- Site-directed Mutagenesis of Proteolytic Antibody Light ChainJournal of Molecular Biology, 1995
- Computer-aided molecular modeling of the binding site architecture for eight monoclonal antibodies that bind a high potency guanidinium sweetenerJournal of Molecular Graphics, 1994
- The human immunoglobulin x locus. Characterization of the duplicated A regionsEuropean Journal of Immunology, 1992
- At the Crossroads of Chemistry and Immunology: Catalytic AntibodiesScience, 1991